Antibody Production Market by Product (Equipment, Consumables), Type (Monoclonal, Polyclonal), Technology (Hybridoma) & by End-User (Biopharmaceutical Companies, Diagnostic Labs, Research Institutes) - Analysis & Global Forecast to 2019

抗体生産の世界市場:抗体生産装置(バイオリアクター、遠心機、限外ろ過装置)、抗体生産消耗品、モノクローナル抗体、ポリクローナル抗体

◆タイトル:Antibody Production Market by Product (Equipment, Consumables), Type (Monoclonal, Polyclonal), Technology (Hybridoma) & by End-User (Biopharmaceutical Companies, Diagnostic Labs, Research Institutes) - Analysis & Global Forecast to 2019
◆商品コード:MAM-BT-3363
◆調査・発行会社:MarketsandMarkets
◆発行日:2015年5月1日
◆ページ数:164
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、抗体生産の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観、産業動向、市場シェア分析、製品別分析、種類別分析、技術別分析、需要先別分析、市場規模及び予測、競争状況、関連企業分析などの情報をお届けいたします。

Over the years, the antibody production market has witnessed various technological advancements in order to produce antibodies that meet the needs of biotechnology and biopharmaceutical companies, diagnostic laboratories, and research institutes. These advancements have led to the development of hybridoma-free technologies such as recombinant technology and antibody phage-display technology. Due to the advantages of this technology, such as ease of use and versatility, the hybridoma-free technology is set to replace technologies that use hybridomas and animals in due course.

In 2014, the consumables segment accounted for the largest share of the global antibody production market, by product; the monoclonal antibody segment accounted for the largest share of the antibody production market, by type; the hybridoma technology segment accounted for the largest share of antibody production market, by technology; while the biotechnology and pharmaceutical companies segment accounted for the largest share of the antibody production market, by end user.

In 2014, North America accounted for the largest share of the global antibody production market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, the antibody production market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues of antibody producers and the manufacturers of equipment and consumables involved in antibody production.

The global antibody production market witnesses high competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various strategies (agreements, partnerships, joint ventures, collaborations, geographical expansions, and acquisitions) to increase their market shares and to establish a strong foothold in the global market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the antibody production market. The report analyzes the antibody production market, by product, type, technology, and end user

• Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the antibody production market

• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various antibody production technologies across regions

• Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the antibody production market

• Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the antibody production market

【レポートの目次】

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 19)
2.1.1 Research Methodology Steps
2.1.2 Secondary and Primary Research Methodology
2.1.2.1 Secondary Research
2.1.3 Key Data From Secondary Sources
2.1.3.1 Primary Research
2.1.3.2 Key Industry Insights
2.1.4 Key Data From Primary Sources
2.1.5 Key Insights From Primary Sources
2.1.6 Market Size Estimation Methodology
2.1.7 Market Forecast Methodology
2.1.8 Market Data Validation and Triangulation
2.1.9 Assumptions for the Study

3 Executive Summary (Page No. – 30)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 36)
4.1 Global Antibody Production Market
4.2 Antibody Production Market, By Region and End User
4.3 Geographic Snapshot of the Antibody Production Market
4.4 Antibody Production Market, By Technology (2014 vs. 2019)

5 Market Overview (Page No. – 40)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increasing Global Demand for Monoclonal Antibodies (MABS)
5.3.1.2 Rising R&D Expenditure of Pharmaceutical and Biotechnology Companies
5.3.2 Challenges
5.3.2.1 High Cost of Primary Antibodies
5.3.3 Opportunities
5.3.3.1 Emerging Markets of India and China
5.3.3.2 Rising Demand for Protein Therapeutics
5.3.3.1 Increasing Risk of Infectious Diseases

6 Industry Trends (Page No. – 49)
6.1 Supply Chain Analysis
6.1.1 Prominent Companies
6.1.2 Small and Medium Enterprises
6.1.3 End Users
6.1.4 Key Influencers
6.1.4.1 Investors, Venture Capitalists, and Funding Bodies
6.1.4.2 Regulatory Bodies
6.1.4.3 Academic Researchers/Organizations
6.2 Pest Analysis
6.2.1 Political Factors
6.2.2 Economic Factors
6.2.3 Social Factors
6.2.4 Technological Factors

7 Antibody Production Market, By Product (Page No. – 53)
7.1 Introduction
7.2 Equipment
7.2.1 Bioreactors
7.2.2 Centrifuges
7.2.3 Ultrafiltration Systems
7.2.4 Other Equipment
7.3 Consumables
7.3.1 Sera
7.3.2 Media
7.3.3 Reagents and Buffers
7.3.4 Chromatography Resins and Columns

8 Antibody Production Market, By Type (Page No. – 61)
8.1 Introduction
8.2 Monoclonal Antibodies
8.3 Polyclonal Antibodies

9 Global Antibody Production Market, By Technology (Page No. – 67)
9.1 Introduction
9.1.1 Hybridoma Technology
9.1.2 Hybridoma-Free Technology

10 Antibody Production Market, By End User (Page No. – 71)
10.1 Introduction
10.1.1 Pharmaceutical and Biotechnology Companies
10.1.2 Diagnostic Laboratories
10.1.3 Research Institutes

11 Antibody Production Market, By Region (Page No. – 77)

12 Competitive Landscape (Page No. – 123)
12.1 Overview
12.2 Market Share Analysis, Antibody Production Market
12.2.1 Ge Healthcare
12.2.2 Thermo Fisher Scientific, Inc.
12.2.3 Sartorius AG
12.3 Competitive Situation and Trends
12.3.1 Agreements/Partnerships/Joint Ventures/Collaborations
12.3.2 Expansions
12.3.3 New Product Launches
12.3.4 Acquisitions
12.3.5 Others

13 Company Profiles (Page No. – 134)
13.1 Introduction
13.2 Ge Healthcare
13.2.1 Business Overview
13.2.2 Product Portfolio
13.2.3 Key Strategies
13.2.4 Recent Developments
13.3 Thermo Fisher Scientific, Inc.
13.3.1 Business Overview
13.3.2 Product Portfolio
13.3.3 Key Strategies
13.3.4 Recent Developments
13.4 Sartorius AG
13.4.1 Business Overview
13.4.2 Products & Services
13.4.3 Key Strategy
13.4.4 Recent Developments
13.5 Merck Millipore
13.5.1 Business Overview
13.5.2 Product Portfolio
13.5.3 Key Strategy
13.5.4 Recent Developments
13.6 Sigma-Aldrich Corporation
13.6.1 Business Overview
13.6.2 Product Portfolio
13.6.3 Key Strategy
13.6.4 Recent Developments
13.7 Abcam PLC
13.7.1 Business Overview
13.7.2 Product Portfolio
13.7.3 Key Strategies
13.7.4 Recent Developments
13.8 Roche Applied Science
13.8.1 Business Overview
13.8.2 Product Portfolio
13.8.3 Key Strategy
13.8.4 Recent Developments
13.9 Amgen, Inc.
13.9.1 Business Overview
13.9.2 Product Portfolio
13.9.3 Key Strategies
13.9.4 Recent Developments
13.10 Sanofi S. A.
13.10.1 Business Overview
13.10.2 Product Portfolio
13.10.3 Key Strategies
13.10.4 Recent Developments
13.11 Rockland Immunochemicals, Inc.
13.11.1 Business Overview
13.11.2 Product Portfolio
13.11.3 Key Strategy
13.11.4 Recent Developments

14 Appendix (Page No. – 170)
14.1 Discussion Guide
14.2 Company Developments (2012–2014)
14.2.1 Ge Healthcare
14.2.2 Thermo Fisher Scientific, Inc.
14.2.3 Sartorius AG
14.2.4 Merck Millipore
14.2.5 Sigma-Aldrich Corporation
14.2.6 Roche Applied Science
14.2.7 Amgen, Inc.
14.3 Introducing RT: Real-Time Market Intelligence
14.4 Available Customizations
14.5 Related Reports

List of Tables (95 Tables)

Table 1 Increasing Global Demand for Monoclonal Antibodies is Propelling the Growth of the Antibody Production Market
Table 2 High Costs of Primary Antibodies is Restraining the Growth of the Antibody Production Market
Table 3 India and China Offer Huge Potential for the Antibody Production Market
Table 4 Antibody Production Market Size, By Product, 2012–2019 ($Million)
Table 5 Antibody Production Equipment Market Size, By Region, 2012–2019 ($Million)
Table 6 Antibody Production Consumables Market Size, By Region, 2012–2019 ($Million)
Table 7 Market Size, By Type, 2012–2019 ($Million)
Table 8 Comparison Between Monoclonal and Polyclonal Antibodies
Table 9 Market Size for Monoclonal Antibodies, By Region, 2012–2019 ($Million)
Table 10 Market Size for Polyclonal Antibodies, By Region, 2012–2019 ($Million)
Table 11 Global Market Size, By Technology, 2012–2019 ($Million)
Table 12 Hybridoma Technology Market Size, By Region, 2012–2019 ($Million)
Table 13 Hybridoma-Free Technology Market Size, By Region, 2012–2019 ($Million)
Table 14 Antibody Production Market Size, By End User, 2012–2019 ($Million)
Table 15 Market Size for Pharmaceutical and Biotechnology Companies, 2012–2019 ($Million)
Table 16 Market Size for Diagnostic Laboratories, By Region, 2012–2019 ($Million)
Table 17 Market Size for Research Institutes, By Region, 2012–2019 ($Million)
Table 18 Market Size, By Region, 2012–2019 ($Million)
Table 19 North America: Antibody Production Market Size, By Country, 2012–2019 ($Million)
Table 20 North America: Market Size, By Product, 2012–2019 ($Million)
Table 21 North America: Market Size, By Type, 2012–2019 ($Million)
Table 22 North America: Market Size, By Technology, 2012–2019 ($Million)
Table 23 North America: Market Size, By End User, 2012–2019 ($Million)
Table 24 U.S.: Antibody Production Market Size, By Product, 2012–2019 ($Million)
Table 25 U.S.: Market Size, By Type, 2012–2019 ($Million)
Table 26 U.S.: Market Size, By Technology, 2012–2019 ($Million)
Table 27 U.S.: Market Size, By End User, 2012–2019 ($Million)
Table 28 Canada: Antibody Production Market Size, By Product, 2012–2019 ($Million)
Table 29 Canada: Market Size, By Type, 2012–2019 ($Million)
Table 30 Canada: Market Size, By Technology, 2012–2019 ($Million)
Table 31 Canada: Market Size, By End User, 2012–2019 ($Million)
Table 32 Europe: Antibody Production Market Size, By Country, 2012–2019 ($Million)
Table 33 Europe: Market Size, By Product, 2012–2019 ($Million)
Table 34 Europe: Market Size, By Type, 2012–2019 ($Million)
Table 35 Europe: Market Size, By Technology, 2012–2019 ($Million)
Table 36 Europe: Market Size, By End User, 2012–2019 ($Million)
Table 37 Germany: Antibody Production Market Size, By Product, 2012–2019 ($Million)
Table 38 Germany: Market Size, By Type, 2012–2019 ($Million)
Table 39 Germany: Market Size, By Technology, 2012–2019 ($Million)
Table 40 Germany: Market Size, By End User, 2012–2019 ($Million)
Table 41 U.K.: Antibody Production Market Size, By Product, 2012–2019 ($Million)
Table 42 U.K.: Market Size, By Type, 2012–2019 ($Million)
Table 43 U.K.: Market Size, By Technology, 2012–2019 ($Million)
Table 44 U.K.: Market Size, By End User, 2012–2019 ($Million)
Table 45 France: Antibody Production Market Size, By Product, 2012–2019 ($Million)
Table 46 France: Market Size, By Type, 2012–2019 ($Million)
Table 47 France: Market Size, By Technology, 2012–2019 ($Million)
Table 48 France: Market Size, By End User, 2012–2019 ($Million)
Table 49 RoE: Antibody Production Market Size, By Product, 2012–2019 ($Million)
Table 50 RoE: Market Size, By Type, 2012–2019 ($Million)
Table 51 RoE: Market Size, By Technology, 2012–2019 ($Million)
Table 52 RoE: Market Size, By End User, 2012–2019 ($Million)
Table 53 Asia: Antibody Production Market Size, By Country, 2012–2019 ($Million)
Table 54 Asia: Market Size, By Product, 2012–2019 ($Million)
Table 55 Asia: Market Size, By Type, 2012–2019 ($Million)
Table 56 Asia: Market Size, By Technology, 2012–2019 ($Million)
Table 57 Asia: Market Size, By End User, 2012–2019 ($Million)
Table 58 Japan: Antibody Production Market Size, By Product, 2012–2019 ($Million)
Table 59 Japan: Market Size, By Type, 2012–2019 ($Million)
Table 60 Japan: Market Size, By Technology, 2012–2019 ($Million)
Table 61 Japan: Market Size, By End User, 2012–2019 ($Million)
Table 62 China: Antibody Production Market Size, By Product, 2012–2019 ($Million)
Table 63 China: Market Size, By Type, 2012–2019 ($Million)
Table 64 China: Market Size, By Technology, 2012–2019 ($Million)
Table 65 China: Market Size, By End User, 2012–2019 ($Million)
Table 66 India: Antibody Production Market Size, By Product, 2012–2019 ($Million)
Table 67 India: Market Size, By Type, 2012–2019 ($Million)
Table 68 India: Market Size, By Technology, 2012–2019 ($Million)
Table 69 India: Market Size, By End User, 2012–2019 ($Million)
Table 70 RoA: Antibody Production Market Size, By Product, 2012–2019 ($Million)
Table 71 RoA: Market Size, By Type, 2012–2019 ($Million)
Table 72 RoA: Market Size, By Technology, 2012–2019 ($Million)
Table 73 RoA: Market Size, By End User, 2012–2019 ($Million)
Table 74 RoW: Market Size, By Region, 2012–2019 ($Million)
Table 75 RoW: Market Size, By Product, 2012–2019 ($Million)
Table 76 RoW: Market Size, By Type, 2012–2019 ($Million)
Table 77 RoW: Market Size, By Technology, 2012–2019 ($Million)
Table 78 RoW: Market Size, By End User, 2012–2019 ($Million)
Table 79 Latin America: Antibody Production Market Size, By Product, 2012–2019 ($Million)
Table 80 Latin America: Market Size, By Type, 2012–2019 ($Million)
Table 81 Latin America: Market Size, By Technology, 2012–2019 ($Million)
Table 82 Latin America: Market Size, By End User, 2012–2019 ($Million)
Table 83 Middle East and Africa: Antibody Production Market Size, By Product, 2012–2019 ($Million)
Table 84 Middle East and Africa: Market Size, By Type, 2012–2019 ($Million)
Table 85 Middle East and Africa: Market Size, By Technology, 2012–2019 ($Million)
Table 86 Middle East and Africa: Market Size, By End User, 2012–2019 ($Million)
Table 87 Pacific Countries: Antibody Production Market Size, By Product, 2012–2019 ($Million)
Table 88 Pacific Countries: Market Size, By Type, 2012–2019 ($Million)
Table 89 Pacific Countries: Market Size, By Technology, 2012–2019 ($Million)
Table 90 Pacific Countries:Market Size, By End User, 2012–2019 ($Million)
Table 91 Agreements/Partnerships/Joint Ventures/Collaborations, 2012–2015
Table 92 Expansion, 2012–2015
Table 93 New Product Launches, 2012–2015
Table 94 Acquisitions, 2012–2015
Table 95 Other Strategies, 2012–2015

List of Figures (43 Figures)

Figure 1 Antibody Production Market Segmentation
Figure 2 Global Antibody Production Market : Research Methodology Steps
Figure 3 Sampling Frame: Primary Research
Figure 4 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Market Forecast Methodology
Figure 8 Data Triangulation Methodology
Figure 9 Consumables Market to Witness Higher CAGR of 12.8% From 2014 to 2019
Figure 10 Monoclonal Antibodies Segment Commanded Higher Market Share in 2014
Figure 11 Hybridoma-Free Technology Segment to Grow at the Higher CAGR From 2014 to 2019
Figure 12 Biotechnology and Pharmaceutical Companies Dominate the Antibody Production End-Users Market
Figure 13 Asia is Slated to Witness the Highest Growth in this Market in the Forecast Period
Figure 14 Antibody Production : Market Overview
Figure 15 Biotechnology and Pharmaceutical Companies Dominated the Antibody Production Market in 2014
Figure 16 Asia to Witness the Highest Growth Rate During the Forecast Period
Figure 17 Hybridoma Technology Commanded the Largest Share
Figure 18 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Supply Chain: Direct Distribution is the Preferred Strategy
Figure 20 Followed By Prominent Players
Figure 21 The Consumables Segment is Expected to Grow at A Faster Pace From 2014 to 2019
Figure 22 Polyclonal Antibodies Segment is Expected to Grow at A Faster Rate Than Monoclonal Antibodies During the Forecast Period
Figure 23 Hybridoma-Free Technology to Grow at the Highest Rate During the Forecast Period
Figure 24 Pharmaceutical and Biotechnology Companies End-User Segment to Grow at the Highest Rate During the Forecast Period
Figure 25 North America Commanded the Largest Share of the Global Antibody Production Market in 2014
Figure 26 The U.S. to Witness the Highest Growth in this Market in North America
Figure 27 Germany to Witness the Highest Growth in this Market in Europe
Figure 28 China is the Fastest-Growing Antibody Production Market in Asia
Figure 29 RoW Accounted for A Share of 9% of the Global Antibody Production Market in 2014
Figure 30 Agreements/Partnerships/Joint Ventures/Collaborations Was the Key Growth Strategy for Market Players
Figure 31 Global Antibody Production, Market Share, By Key Player, 2014
Figure 32 Battle for Market Share: Agreements/Partnerships/Joint Ventures/ Collaborations Was the Key Strategy
Figure 33 Geographic Revenue Mix of Top Market Players
Figure 34 General Electric Company: Company Snapshot
Figure 35 Thermo Fisher Scientific, Inc.: Company Snapshot
Figure 36 Sartorius AG: Company Snapshot
Figure 37 Merck Millipore: Company Snapshot
Figure 38 Sigma-Aldrich Corporation: Company Snapshot
Figure 39 Abcam PLC: Company Snapshot
Figure 40 Roche Applied Science: Company Snapshot
Figure 41 Amgen, Inc.: Company Snapshot
Figure 42 Sanofi S. A.: Company Snapshot
Figure 43 Rockland Immunochemicals, Inc.: Company Snapshot

【レポートのキーワード】

抗体生産装置、抗体生産消耗品、バイオリアクター、遠心機、限外ろ過装置、セラ、メディア、試薬、バッファー、クロマトグラフィー樹脂/カラム、モノクローナル抗体、ポリクローナル抗体、ハイブリドーマ技術、抗体製造、製薬、バイオ技術

★調査レポート[抗体生産の世界市場:抗体生産装置(バイオリアクター、遠心機、限外ろ過装置)、抗体生産消耗品、モノクローナル抗体、ポリクローナル抗体] ( Antibody Production Market by Product (Equipment, Consumables), Type (Monoclonal, Polyclonal), Technology (Hybridoma) & by End-User (Biopharmaceutical Companies, Diagnostic Labs, Research Institutes) - Analysis & Global Forecast to 2019 / MAM-BT-3363) 販売に関する免責事項
[抗体生産の世界市場:抗体生産装置(バイオリアクター、遠心機、限外ろ過装置)、抗体生産消耗品、モノクローナル抗体、ポリクローナル抗体] ( Antibody Production Market by Product (Equipment, Consumables), Type (Monoclonal, Polyclonal), Technology (Hybridoma) & by End-User (Biopharmaceutical Companies, Diagnostic Labs, Research Institutes) - Analysis & Global Forecast to 2019 / MAM-BT-3363) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆